| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
8,578.15
|
|
Change (%)
|
-32.80 (-0.38%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
8,558.10
-
8,690.35
|
|
52-Week Range (RS)
|
7,630.00
-
10,653.05
|
|
Beta (1 Year)
|
0.36
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Astrazeneca Pharma India to discuss results |
| Astrazeneca Pharma India gets CDSCO approval for Acalabrutinib tablets |
| Astrazeneca Pharma India standalone net profit rises 5.64% in the December 2025 quarter |
| Astrazeneca Pharma India schedules board meeting |
| Volumes jump at Timken India Ltd counter |
| AstraZeneca Pharma gets CDSCO nod for import and sale of Datverzo in India |
|
|
|
| Incoporation Year : 1979 |
| Chairman : Shilpa Divekar Nirula |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Astrazeneca Pharma India Ltd
Blk N1 12th Flr Manyata Embass,
Rachenahalli Outer Ring Road,
Bangalore,
Karnataka-560045 |
Phone:91-080-67748000
Fax:91-080-67748557 |
| E-Mail : comp.secy@astrazeneca.com |
| URL : http://www.astrazeneca.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
14-May-2026 |
8350.10 |
2.73 |
| 1Month |
21-Apr-2026 |
8454.40 |
1.46 |
| 3Month |
23-Feb-2026 |
8871.90 |
-3.31 |
| 6Month |
21-Nov-2025 |
8993.95 |
-4.62 |
| 1Year |
21-May-2025 |
7944.65 |
7.97 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Nippon India Small Cap Fund |
0.75 |
541.96 |
| Bandhan Large & Mid Cap Fund |
0.72 |
120.09 |
| Bandhan Innovation Fund |
3.63 |
76.30 |
| ICICI Pru Quality Fund |
3.01 |
65.35 |
| Nippon India Pharma Fund |
0.61 |
51.39 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
27,645.45 |
0.72 |
35,921.55 |
25,164.00 |
58,746.58 |
| Glaxosmithkline Pharmaceuticals Ltd |
2,320.75 |
-1.14 |
3,515.95 |
2,218.00 |
39,314.91 |
| Pfizer Ltd |
4,658.70 |
-0.58 |
5,987.65 |
4,461.80 |
21,312.50 |
| Sanofi Consumer Healthcare India Ltd |
4,709.85 |
-2.44 |
5,954.00 |
3,950.50 |
10,847.08 |
| Procter & Gamble Health Ltd |
5,441.20 |
1.86 |
6,700.00 |
4,699.70 |
9,032.06 |
|
|
|
|